U.S. Innovation & Competition Act Likely Passes 2022 | Capitol Street

Published On: 03/15/2022 ▪

U.S. Innovation & Competition Act Likely Passes 2022

Access Memo Here

View More Posts

Diagnostic Test FDA Reform Pathway Updated
Published On: 06/12/2022
FDA User Fees Pass House, Senate Is Next
Published On: 06/10/2022
FTC Pharma Bills May Be In Mix With BBB
Published On: 06/08/2022
Manchin: Drug Reform Needed
Published On: 06/02/2022
Medicare Trustees Say Solvency Till 2028
Published On: 06/02/2022
What Is Hospital At Home? Hint: Plans, Hospitals & Primary Care Co’s Support It
Published On: 05/24/2022
Legislation That Is Actually Moving
Published On: 05/18/2022
VALID Act Regulates LDTs and In-Vitro Tests
Published On: 05/18/2022
Diagnostic Testing Legislation Framework
Published On: 05/17/2022
PBM Anti-Competitive Practices & “The Big 3”
Published On: 05/05/2022

What insights can we share with you?

Contact Info

900 19th Street Northwest
Washington, DC 20006
United States
team@capitol-street.com

PastedGraphic-26